Neurodevelopmental outcome in Preterm Infants with Pathologic evidence of Fetal Inflammatory Response (Poster 8)
Monday, May 1, 2023
1:00 PM – 2:30 PM ET
Location: Convention Center: 145 AB
Publication Number: 3315.7
Yasmeen J. Alayli, University of Texas Southwestern Medical School, Dallas, TX, United States; Sameer Gajjar, University of Texas Southwestern Medical School, Dallas, TX, United States; Zeeshawn Malik, University of Texas Southwestern Medical School, Frisco, TX, United States; Reeha Y. Shahdad, University of Texas Southwestern Medical Center, Frisco, TX, United States; Larry S. Brown, Parkland Health, Dallas, TX, United States; Roy Heyne, University of Texas Southwestern Medical School, dallas, TX, United States; Charles R. Rosenfeld, Univ. of Texas Southwestern Medical Ctr, Dallas, TX, United States; Lina Chalak, UT Southwestern.edu, DALLAS, TX, United States; Imran N. Mir, University of Texas Southwestern Medical School, Plano, TX, United States
Presenting Author(s)
Yasmeen J. Alayli (she/her/hers)
Medical Student University of Texas Southwestern Medical School Dallas, Texas, United States
Disclosure(s):
Yasmeen J. Alayli: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Sameer Gajjar, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Zeeshawn Malik, n/a: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Reeha Y. Shahdad, n/a: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Larry S. Brown, MS. CPH: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Roy Heyne, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Charles R. Rosenfeld, MD: Pfizer Inc (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds); TEVA Pharmaceuticals (Ongoing) (Products/Services: Ownership Interest including individual stocks, stock options, excluding diversified mutual funds)
Lina Chalak, MD MSCS: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Imran N. Mir, MD: I do not have any relevant financial / non-financial relationships with any proprietary interests.